Displaying drugs 14176 - 14200 of 14695 in total
Azeliragon
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Ritanserin
Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational
LY-518674
LY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Investigational
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Viminol
Experimental
Cibenzoline
Experimental
Budipine
Experimental
Sequifenadine
Experimental
Picloxydine
Experimental
Sulbentine
Experimental
Xibornol
Experimental
Guanoclor
Experimental
Clofibride
Experimental
Bisoxatin acetate
Experimental
TAK-428
TAK-428 is a drug for treating diabetic neuropathy. It is based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and regenerated by stimulating an increase in neurotrophic factors.
Investigational
Matched Description: … based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and …
Phenoxypropazine
Phenoxypropazine is a non-selective and irreversible monoamine oxidase enzyme inhibitor (MAOI), belonging to the hydrazine chemical class. It was marketed as an antidepressant in 1961 but was later withdrawn in 1966 because of its hepatotoxic potential.
Withdrawn
Matched Description: … Phenoxypropazine is a non-selective and irreversible monoamine oxidase enzyme inhibitor (MAOI), belonging …
GZ-389988
GZ-389988 is under investigation in clinical trial NCT02845271 (Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee).
Investigational
Matched Description: … investigation in clinical trial NCT02845271 (Proof-of-concept Study to Assess the Efficacy, Tolerability and …
7-Deazaguanine
Experimental
Displaying drugs 14176 - 14200 of 14695 in total